The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 of 6 cited sources checked · 0 supported · 0 flagged · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Normal and diabetic group sizes are reversed for the CIGMA comparison
MinorThe methods say the CIGMA comparison used 12 normal subjects and 11 diabetic patients, but the results report 11 normal subjects and 12 diabetic subjects.
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 3,501–3,600 of 31,469
Vergès, B. L., Patois‐Vergès, B., Cohen, M., Lucas, B., Galland-Jos, C., & Casillas, J.-M. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01262.x · Cited by 91
Bajaj, S., Nigam, P., Luthra, A., Pandey, R. M., Kondal, D., Bhatt, S. P., Wasir, J. S., & Misra, A. (2009) · PubMed · Cited by 93
Wannamethee, S. G., Whincup, P. H., Rumley, A., & Lowe, G. D. O. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02643.x · Cited by 92
Petta, S., Grimaudo, S., Cammà, C., Cabibi, D., Marco, V. D., Licata, G., Pipitone, R. M., & Craxı̀, A. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.01.007 · Cited by 92
High-fat diets promote insulin resistance through cytokine gene expression in growing female rats
Johnson‐Flanagan, A. M., Brown, J. L., Santiago, C. A., Aad, P. Y., SPICER, L. J., & Spicer, M. T. (2007) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2007.06.005 · Cited by 91
HOMA Index to Assess Insulin Resistance in Renal Failure Patients
Shoji, T., Emoto, M., & Nishizawà, Y. (2001) · The Nephron journals/Nephron journals · doi:10.1159/000046098 · Cited by 92
Naissides, M., Mamo, J. C. L., James, A. P., & Pal, S. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.06.027 · Cited by 91
Mackawy, A. M. H., & Badawy, M. E.-S. (2014) · Meta Gene · doi:10.1016/j.mgene.2014.07.002 · Cited by 93
Jia, S., Hu, Y., Zhang, W., Zhao, X., Chen, Y., Sun, C., Li, X., & Chen, K. (2015) · Food & Function · doi:10.1039/c4fo00993b · Cited by 92
Effect of weight loss on coronary circulation and adiponectin levels in obese women
Coppola, A., Marfella, R., Coppola, L., Tagliamonte, E., Fontana, D., Liguori, E., Cirillo, T., Cafiero, M., Natale, S., & Astarita, C. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.12.087 · Cited by 92
Johansson, H. A., Gandini, S., Guerrieri‐Gonzaga, A., Iodice, S., Ruscica, M., Bonanni, B., Gulisano, M., Magni, P., Formelli, F., & DeCensi, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0553 · Cited by 91
Wiegand, S., l’Allemand, D., Hübel, H., Krude, H., Bürmann, M., Martus, P., Grüters, A., & Holl, R. W. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0570 · Cited by 94
Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome
Fenkçi, S. M., Fenkçi, V., Öztekin, Ö., Rota, S., & Karagenç, N. (2008) · Human Reproduction · doi:10.1093/humrep/den109 · Cited by 92
Elevated triglycerides/HDL-cholesterol ratio associated with insulin resistance.
González-Chávez, A., Simental‐Mendía, L. E., & Elizondo-Argueta, S. (2011) · PubMed · Cited by 92
Rodríguez, L. A., Madsen, K. A., Cotterman, C., & Lustig, R. H. (2016) · Public Health Nutrition · doi:10.1017/s1368980016000057 · Cited by 92
Yang, J. D., Abdelmalek, M. F., Guy, C. D., Gill, R. M., Lavine, J. E., Yates, K. P., Klair, J. S., Terrault, N. A., Clark, J. M., Ünalp–Arida, A., et al. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.07.034 · Cited by 93
de Moraes, A. C. F., de Almeida-Pititto, B., Fernandes, G. D. R., Gomes, E. P., Pereira, A. C., & Ferreira, S. R. G. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0261-x · Cited by 97
Inflammatory markers in women with a recent history of gestational diabetes mellitus
Benedetto, A. D., Russo, G. T., Corrado, F., Cesare, E. D., Alessi, E., Nicocia, G., D’Anna, R., & Cucinotta, D. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03345527 · Cited by 93
Cappiello, V., Ronchi, C. L., Morpurgo, P., Epaminonda, P., Arosio, M., Beck-Peccoz, P., & Spada, A. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1470189 · Cited by 92
Ruivard, M., Lainé, F., Ganz, T., Olbina, G., Westerman, M., Nemeth, E., Rambeau, M., Mazur, A., Gerbaud, L., Tournilhac, V., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.01.029 · Cited by 89
Kranendonk, M. E. G., van Herwaarden, J. A., Stupkova, T., Jager, W. D., Vink, A., Moll, F. L., Kalkhoven, E., & Visseren, F. L. J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.035 · Cited by 91
Kovacova, Z., Tharp, W. G., Liu, D., Wei, W., Xie, H., Collins, S., & Pratley, R. E. (2016) · Obesity · doi:10.1002/oby.21418 · Cited by 85
Lorenzo, C., Haffner, S. M., Stančáková, A., & Laakso, M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1144 · Cited by 92
Blouet, C., Mariotti, F., Azzout‐Marniche, D., Bos, C., Mathé, V., Tomé, D., & Huneau, J. (2006) · Journal of Nutrition · doi:10.1093/jn/136.7.1849 · Cited by 93
Yang, W., Chen, L., Ji, Q., Liu, X., Ma, J., Tandon, N., Bhattacharyya, A., Kumar, A., Kim, K.-W., Yoon, K., et al. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01323.x · Cited by 91
Belski, R., Mori, T. A., Puddey, I. B., Sipsas, S., Woodman, R. J., Ackland, T. R., Beilin, L. J., Dove, E. R., Carlyon, N. B., Jayaseena, V, et al. (2011) · International Journal of Obesity · doi:10.1038/ijo.2010.213 · Cited by 91
Zuo, H., Shi, Z., Yuan, B., Dai, Y., Wu, G., & Hussain, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054615 · Cited by 91
Determinants of Insulin‐resistant Phenotypes in Normal‐weight and Obese Black African Women
Jennings, C., Lambert, E. V., Collins, M., Joffe, Y. T., Levitt, N. S., & Goedecke, J. H. (2008) · Obesity · doi:10.1038/oby.2008.233 · Cited by 90
Impact of BMI on the incidence of metabolic abnormalities in metabolically healthy men
Chang, Y., Ryu, S., Suh, B.-S., Yun, K. E., Kim, C.-W., & Cho, S.-I. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.247 · Cited by 90
Open questions about metabolically normal obesity
Pataky, Z., Bobbioni-Harsch, E., & Golay, A. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.235 · Cited by 93
Pivovarova‐Ramich, O., Gögebakan, Ö., Klöting, N., Sparwaßer, A., Weickert, M. O., Haddad, I., Nikiforova, V. J., Bergmann, A., Kruse, M., Seltmann, A., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2839 · Cited by 91
Bligh, H. F. J., Godsland, I. F., Frost, G. S., Hunter, K., Murray, P., MacAulay, K., Hyliands, D., Talbot, D. C. S., Casey, J., MULDER, T. P. J., et al. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114514004012 · Cited by 95
Reggio, S., Rouault, C., Poitou, C., Bichet, J.-C., Prifti, E., Bouillot, J., Rizkalla, S. W., Lacasa, D., Tordjman, J., & Clément, K. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4304 · Cited by 94
Dasgupta, K., Rosenberg, E., Joseph, L., Cooke, A. B., Trudeau, L., Bacon, S., Chan, D., Sherman, M. H., RABASA-LHORET, R. P. R., Daskalopoulou, S. S., et al. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12874 · Cited by 96
High Prevalence of Undiagnosed Insulin Resistance in Non-Diabetic Subjects with Parkinson’s Disease
Hogg, E. J., Athreya, K., Basile, C., Tan, E. E., Kamiński, J. P., & Tagliati, M. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-181305 · Cited by 91
Amin, M. M., Rafiei, N., Poursafa, P., Ebrahimpour, K., Mozafarian, N., Shoshtari-Yeganeh, B., Hashemi, M., & Kelishadi, R. (2018) · Environmental Science and Pollution Research · doi:10.1007/s11356-018-3354-7 · Cited by 91
Ren, X., Yin, R., Hou, D., Xue, Y., Zhang, M., Diao, X., Zhang, Y., Wu, J., Hu, J., Hu, X., et al. (2018) · Nutrients · doi:10.3390/nu10101509 · Cited by 96
Hu, X., Rong, S., Wang, Q., Sun, T., Bao, W., Chen, L., & Liu, L. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108542 · Cited by 92
Nkwana, M. R., Monyeki, K. D., & Lebelo, S. L. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18010281 · Cited by 96
Yang, Y., Zhang, J., Ma, D., Zhang, M., Hu, S., Shao, S., & Gong, C. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130491 · Cited by 92
Bao, Y., Zhou, M., Lu, Z., Li, H., Wang, Y., Sun, L., Gao, M., Wei, M., & Jia, W. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04065.x · Cited by 89
Saarinen, A., Saukkonen, T. T., Kivelä, T., Lahtinen, U., Laine, C. M., Somer, M., Toiviainen‐Salo, S., Cole, W. G., Lehesjoki, A., & Mäkitie, O. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03680.x · Cited by 88
León-Latre, M., Moreno‐Franco, B., Andres, E. M., Ledesma, M., Laclaustra, M., Alcalde, V., Peñalvo, J. L., Ordovás, J. M., & Casasnovas, J. A. (2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.10.015 · Cited by 105
Adipose tissue fatty acids and insulin sensitivity in elderly men
Iggman, D., Ärnlöv, J., Vessby, B., Cederholm, T., Sjögren, P., & Risérus, U. (2010) · Diabetologia · doi:10.1007/s00125-010-1669-0 · Cited by 93
Teranishi, T., Ohara, T., Maeda, K., Zenibayashi, M., Kouyama, K., Hirota, Y., Kawamitsu, H., Fujii, M., Sugimura, K., & Kasuga, M. (2007) · Metabolism · doi:10.1016/j.metabol.2007.06.005 · Cited by 93
Gibson, A., Buchholz, A. C., & Ginis, K. A. M. (2008) · Spinal Cord · doi:10.1038/sc.2008.32 · Cited by 91
Alemán-Mateo, H., Macias, L., Esparza‐Romero, J., Astiazarán‐García, H., & Blancas, A. L. (2012) · Clinical Interventions in Aging · doi:10.2147/cia.s32356 · Cited by 92
Dock‐Nascimento, D. B., de Aguilar‐Nascimento, J. E., Faria, M. H. C. P., Caporossi, C., Slhessarenko, N., & Waitzberg, D. L. (2012) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607111422719 · Cited by 91
Association Between Liver Fibrosis and Insulin Sensitivity in Chronic Hepatitis C Patients
Taura, N., Ichikawa, T., Hamasaki, K., et al. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00835.x · Cited by 91
Cortisol and Its Relation to Insulin Resistance before and after Weight Loss in Obese Children
Reinehr, T., & Andler, W. (2004) · Hormone Research in Paediatrics · doi:10.1159/000079841 · Cited by 91
Farhangi, M. A., Alipour, B., Jafarvand, E., & Khoshbaten, M. (2014) · Archives of Medical Research · doi:10.1016/j.arcmed.2014.11.001 · Cited by 94
Zacchè, M. M., Caputo, L., Filippis, S., Zacchè, G., Dindelli, M., & Ferrari, A. G. (2009) · Gynecological Endocrinology · doi:10.1080/09513590903015544 · Cited by 91
Buscemi, S., Verga, S., Tranchina, M. R., Cottone, S., & Cerasola, G. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02091.x · Cited by 95
Decreased Glucagon‐like Peptide 1 Release after Weight Loss in Overweight/Obese Subjects
Adam, T. C., Jocken, J. W. E., & Westerterp‐Plantenga, M. S. (2005) · Obesity Research · doi:10.1038/oby.2005.80 · Cited by 91
Kennedy, L., Bittel, D. C., Kibiryeva, N., Kalra, S. P., Torto, R., & Butler, M. G. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803115 · Cited by 90
Plasma Pentraxin3 is a Novel Marker for Nonalcoholic Steatohepatitis (NASH)
Yoneda, M., Uchiyama, T., Kato, S., Endo, H., Fujita, K., Yoneda, K., Mawatari, H., Iida, H., Takahashi, H., Kirikoshi, H., et al. (2008) · BMC Gastroenterology · doi:10.1186/1471-230x-8-53 · Cited by 91
Ferreira, I., Boreham, C. A., Twisk, J. W. R., Gallagher, A. M., Young, I. S., Murray, L., & Stehouwer, C. D. A. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3280a94e76 · Cited by 91
Hermsdorff, H. H. M., Mansego, M. L., Campión, J., Milagro, F. I., Zulet, M. Á., & Martínez, J. A. (2013) · Cytokine · doi:10.1016/j.cyto.2013.05.028 · Cited by 91
Cardiovascular Risk Factors and Atherosclerosis in Young Women
Knoflach, M., Kiechl, S. J., Penz, D., Zangerle, A., Schmidauer, C., Rossmann, A., Shingh, M., Spallek, R., Griesmacher, A., Bernhard, D., et al. (2009) · Stroke · doi:10.1161/strokeaha.108.525675 · Cited by 91
Reinehr, T., Kratzsch, J., Kiess, W., et al. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803027 · Cited by 91
Konopko-Zubrzycka, M., Baniukiewicz, A., Wróblewski, E., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1083 · Cited by 91
Hubbard, J. S., Rohrmann, S., Landis, P., Metter, E. J., Muller, D. C., Andres, R., Carter, H. B., & Platz, E. A. (2004) · Urology · doi:10.1016/j.urology.2003.09.060 · Cited by 91
Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters
Bilz, S., Samuel, V. T., Morino, K., Savage, D. B., Choi, C. S., & Shulman, G. I. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00355.2005 · Cited by 91
Colao, A., Pivonello, R., Grasso, L. F. S., Auriemma, R. S., Galdiero, M., Savastano, S., & Lombardi, G. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0408 · Cited by 92
Alanine Aminotransferase and Directly Measured Insulin Sensitivity in a Multiethnic Cohort
Hanley, A. J., Wagenknecht, L. E., Festa, A., D'Agostino, R. B., & Haffner, S. M. (2007) · Diabetes Care · doi:10.2337/dc07-0086 · Cited by 92
Lambert, E. V., Goedecke, J. H., Bluett, K., Heggie, K., Claassen, A., Rae, D. E., West, S. J., Dugas, J. P., Dugas, L. R., Meltzer, S., et al. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507172822 · Cited by 90
Bhuiyan, A. R., Srinivasan, S. R., Chen, W., Paul, T. K., & Berenson, G. S. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.02.011 · Cited by 87
Retnakaran, R. R., Qi, Y., Sermer, M., Connelly, P. W., Zinman, B., & Hanley, A. J. (2008) · Diabetes Care · doi:10.2337/dc08-0126 · Cited by 88
Wallander, M., Malmberg, K., Norhammar, A., Rydén, L., & Tenerz, Å. (2007) · Diabetes Care · doi:10.2337/dc07-1552 · Cited by 91
Fernández‐Real, J. M., Bulló, M., Moreno‐Navarrete, J. M., Ricart, W., Ros, E., Estruch, R., & Salas‐Salvadó, J. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2221 · Cited by 90
Reinehr, T., de Sousa, G., & Roth, C. L. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03042.x · Cited by 91
Vischer, U. M., Safar, M. E., Safar, H., Iaria, P., Dudal, K. L., Henry, O., Herrmann, F. R., Ducimetière, P., & Blacher, J. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2008.08.006 · Cited by 92
Mukherjee, S., Shaikh, N. J., Khavale, S., Shinde, G., Meherji, P. K., Shah, N. S., & Maitra, A. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0932 · Cited by 94
Regularly consuming a green/roasted coffee blend reduces the risk of metabolic syndrome
Sarriá, B., Martínez‐López, S., Sierra-Cinos, J. L., García‐Diz, L., Mateos, R., & Bravo, L. (2016) · European Journal of Nutrition · doi:10.1007/s00394-016-1316-8 · Cited by 91
Alterations of serum trace elements in patients with type 2 diabetes
Zhang, H., Yan, C., YANG, Z. K., Zhang, W., Niu, Y., Li, X., Qin, L., & Su, Q. (2017) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2016.12.017 · Cited by 94
Ivković, M., Pantović-Stefanović, M., Dunjić-Kostić, B., Jurišić, V., Lačković, M., Totić-Poznanović, S., Jovanović, A. A., & Damjanović, A. (2016) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2016.01.005 · Cited by 89
Strom Halden, T. A., Asberg, A., Vik, K., Hartmann, A., & Jenssen, T. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft536 · Cited by 89
Garcia, J. M., & Polvino, W. J. (2009) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2008.12.003 · Cited by 89
Eshima, H., Tamura, Y., Kakehi, S., Kurebayashi, N., Murayama, T., Nakamura, K., Kakigi, R., Okada, T., Sakurai, T., Kawamori, R., et al. (2017) · Physiological Reports · doi:10.14814/phy2.13250 · Cited by 88
Lima-Martínez, M. M., Paoli, M., Rodney, M., Balladares, N., Contreras, M., D’Marco, L., & Iacobellis, G. (2016) · Endocrine · doi:10.1007/s12020-015-0710-y · Cited by 92
Motivation, Readiness to Change, and Weight Loss Following Adjustable Gastric Band Surgery
Dixon, J. B., Laurie, C. P., Anderson, M. L., Hayden, M. J., Dixon, M. E., & O'Brien, P. E. (2009) · Obesity · doi:10.1038/oby.2008.609 · Cited by 90
Ahn, C. H., Min, S. H., Lee, D.-H., Oh, T. J., Kim, K. M., Moon, J. H., Choi, S. H., Park, K. S., Jang, H. C., Ha, J., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00191 · Cited by 91
Hajifathalian, K., Mehta, A., Ang, B., Skaf, D., Shah, S. L., Saumoy, M., Dawod, Q., Dawod, E., Shukla, A., Aronne, L., et al. (2021) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2020.08.023 · Cited by 96
Hannukainen, J. C., Borra, R., Linderborg, K. M., Kallio, H. P. T., Kišš, J., Saunavaara, V., Kalliokoski, K. K., Kujala, U. M., Kaprio, J. A., Heinonen, O. J., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.07.029 · Cited by 95
Kumar, R. K., Prakash, S., Chhabra, S., Singla, V., Madan, K., Gupta, S. D., Panda, S. K., Khanal, S. P., & Acharya, S. K. (2012) · PubMed Central · Cited by 94
Fan, P., Liu, H., Wang, Y., Zhang, F., & Bai, H. (2011) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2011.10.010 · Cited by 90
Iguchi, T., Hasegawa, T., Otsuka, K., Matsumoto, K., Yamazaki, T., Nishimura, S., Nakata, S., Ehara, S., Kataoka, T., Shimada, K., et al. (2013) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jet158 · Cited by 91
Yin, Q., Ma, Y., Yan, H., Hou, X., Chen, J., Shen, C., Sun, M., Shang, Y., Dong, S., Zeng, Z., et al. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.07.020 · Cited by 90
Yoga Training Improves Metabolic Parameters in Obese Boys
Seo, D. Y., Lee, S.-R., Figueroa, A., Kim, H. K., Baek, Y. H., Kwak, Y., Kim, N., Choi, T. H., Rhee, B. D., Ko, K. S., et al. (2012) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2012.16.3.175 · Cited by 91
Valenzuela, R., Barrera, C. R., Espinosa, A., Llanos, P., Orellana, P., & Videla, L. A. (2015) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2015.04.002 · Cited by 90
Ley, S. H., Hanley, A. J., Sermer, M., Zinman, B., & O’Connor, D. L. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.028431 · Cited by 90
Perona, J. S., Schmidt Rio‐Valle, J., Ramírez‐Vélez, R., Correa‐Rodríguez, M., Fernández‐Aparicio, Á., & González‐Jiménez, E. (2019) · European Journal of Clinical Investigation · doi:10.1111/eci.13060 · Cited by 90
van Kleef, L. A., Ayada, I., Alferink, L. J. M., Pan, Q., & de Knegt, R. J. (2021) · Hepatology · doi:10.1002/hep.32131 · Cited by 95
Triglyceride glucose index: A new biomarker in predicting cardiovascular risk
Araújo, S. P., Juvanhol, L. L., Bressan, J., & Hermsdorff, H. H. M. (2022) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2022.101941 · Cited by 91
Study of Insulin Resistance in Subclinical Hypothyroidism.
Vyakaranam, S., Vanaparthy, S., Nori, S. N. S., et al. (2014) · PubMed · Cited by 90
Exercise and postprandial lipemia: effect of continuous compared with intermittent activity patterns
Miyashita, M., Burns, S. F., & Stensel, D. J. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.1.24 · Cited by 90
Testosterone decreases adiponectin levels in female to male transsexuals
Berra, M., Armillotta, F., D’Emidio, L., Costantino, A., Martorana, G. E., Pelusi, G., & Meriggiola, M. C. (2006) · Asian Journal of Andrology · doi:10.1111/j.1745-7262.2006.00204.x · Cited by 90
Sjaarda, L. A., Bacha, F. F., Lee, S., Tfayli, H. M., Andreatta, E., & Arslanian, S. A. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.12.050 · Cited by 96
Yeung, D. C. Y., Lam, K. S. L., Wang, Y., Tso, A. W. K., & Xu, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0058 · Cited by 90
Arterial stiffness in 10-year-old children: current and early determinants
Schack‐Nielsen, L., Mølgaard, C., Larsen, D. B., Martyn, C., & Michaelsen, K. F. (2005) · British Journal Of Nutrition · doi:10.1079/bjn20051518 · Cited by 90
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
